Finn Thorup Sellebjerg

Finn Thorup Sellebjerg

Clinical Professor

Member of:

  • Neurology


  1. 2023
  2. Published

    Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience

    Jespersen, F., Petersen, S. L., Andersen, P., Sellebjerg, Finn Thorup, Magyari, M., Sørensen, Per Soelberg & Blinkenberg, M., 2023, In: Multiple Sclerosis and Related Disorders. 76, 7 p., 104829.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

    Hansen, J. S., Gustavsen, S., Roshanisefat, H., Kant, M., Biering-Sørensen, Fin, Andersen, C., Olsson, A., Chow, H. H., Asgari, N., Hansen, J. R., Nielsen, H. H., Hansen, R. M., Petersen, T., Oturai, A. B., Sellebjerg, Finn Thorup, Sædder, E. A., Kasch, H., Rasmussen, P. V., Finnerup, N. B. & Svendsen, K. B., 2023, In: Pharmaceuticals. 16, 8, 18 p., 1079.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis

    El Mahdaoui, S., Husted, S. R., Hansen, M. B., Cobanovic, S., Mahler, M. R., Buhelt, S., von Essen, Marina Rode, Sellebjerg, Finn Thorup & Christensen, J. R., 2023, In: Journal of Neuroimmunology. 381, 6 p., 578128.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85-99 in patients with multiple sclerosis

    Martín Monreal, M. T., Hansen, B. E., Iversen, P. F., Enevold, Christian, Ødum, Niels, Sellebjerg, Finn Thorup, Højrup, P., von Essen, Marina Rode & Nielsen, Claus Henrik, 2023, In: Journal of Autoimmunity. 139, 103092.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis

    Hansen, R. H., von Essen, Marina Rode, Mahler, M. R., Cobanovic, S., Binko, T. S. & Sellebjerg, Finn Thorup, 2023, In: Annals of Neurology. 94, 3, p. 518-530

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response

    DBDS Genomic Consortium, D. G. C., 2023, In: European Journal of Neurology. 30, 5, p. 1425-1434 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study

    Holm, R. P., Wandall-Holm, M. F., Sellebjerg, Finn Thorup & Magyari, M., 2023, In: Frontiers in Neurology. 14, 13 p., 1297709.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study

    Chow, H. H., Talbot, J., Lundell, H., Marstrand, L., Madsen, C. G., Sondergaard, H. B., Hansen, M. B., Sorensen, P. S., Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2023, In: Multiple Sclerosis and Related Disorders. 70, 8 p., 104458.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study

    Roar, M., Nielsen, A. R. H., Berg, J. M., Sirakov, G., Stilund, M., Schäfer, J., Ratzer, R., Fredriksen, Jette Lautrup, Asgari, N., Ashna, S. N., Jensen, H. B., Kant, M., Theódorsdóttir, Á., Illes, Z., Sellebjerg, Finn Thorup, Magyari, M., Schlosser, L. M., Nordborg, H., Wergeland, S. & Sejbaek, T., 2023, In: Multiple Sclerosis and Related Disorders. 80, 8 p., 105127.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control

    von Essen, Marina Rode, Chow, H. H., Holm Hansen, R., Buhelt, S. & Sellebjerg, Finn Thorup, 2023, In: Frontiers in Immunology. 14, 15 p., 1249201.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 923247